Should I buy or sell Sernova stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sernova in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SVA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SVA, but not buy additional shares or sell existing shares. View SVA analyst ratings or view top-rated stocks .

What is Sernova's stock price target for 2024?

1 Wall Street analysts have issued 12-month price targets for Sernova's stock. Their SVA share price targets range from C$1.50 to C$1.50. On average, they anticipate the company's share price to reach C$1.50 in the next twelve months. This suggests a possible upside of 219.1% from the stock's current price. View analysts price targets for SVA or view top-rated stocks among Wall Street analysts .

How have SVA shares performed in 2024?

Sernova's stock was trading at C$0.70 at the start of the year. Since then, SVA stock has decreased by 32.9% and is now trading at C$0.47. View the best growth stocks for 2024 here .

When is Sernova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024. View our SVA earnings forecast .

How were Sernova's earnings last quarter?

Sernova Corp. (TSE:SVA) released its quarterly earnings results on Monday, March, 18th. The company reported ($0.03) earnings per share for the quarter, hitting the consensus estimate of ($0.03).

How do I buy shares of Sernova?

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:SVA

Sernova (SVA) Stock Price, News & Analysis

→ Nerd Investor Reveals Secret To Make Money With A.I. (From InvestorPlace) (Ad)

Free SVA Stock Alerts

C$0.47

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: C$0.46
▼
C$0.51
50-Day Range: C$0.40
▼
C$0.70
52-Week Range: C$0.38
▼
C$1.15

Volume: 173,556 shs
Average Volume: 158,211 shs
Market Capitalization: C$142.60 million

P/E Ratio: N/A
Dividend Yield: 7.86%
Price Target: C$1.50

Stock Analysis Analyst Forecasts Chart Competitors Earnings Headlines

Get Sernova alerts:

Sernova MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 219.1% Upside
C$1.50 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: -0.49
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.90 out of 5 stars

3.0

Analyst's Opinion

Consensus Rating
Sernova has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Sernova has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for SVA.

1.7

Dividend Strength

Dividend Leadership
Sernova is a leading dividend payer. It pays a dividend yield of 7.86%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Sernova does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SVA.

1.4

News and Social Media Coverage

News Sentiment
Sernova has a news sentiment score of -0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Sernova this week, compared to 0 articles on an average week.
MarketBeat Follows
2 people have added Sernova to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sernova insiders have not sold or bought any company stock.
Percentage Held by Insiders
14.54% of the stock of Sernova is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 0.05% of the stock of Sernova is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Sernova is -3.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sernova is -3.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Sernova has a P/B Ratio of 47.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

About Sernova Stock (TSE:SVA)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

SVA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SVA Stock News Headlines

April 13, 2024 | americanbankingnews.com

Sernova (TSE:SVA) Trading 13.9% Higher

April 6, 2024 | americanbankingnews.com

FY2026 EPS Estimates for Sernova Corp. Reduced by Analyst (TSE:SVA)

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

April 6, 2024 | americanbankingnews.com

HC Wainwright Equities Analysts Decrease Earnings Estimates for Sernova Corp. (TSE:SVA)

April 2, 2024 | theglobeandmail.com

Sernova Provides Positive Clinical and Platform Portfolio Update

March 14, 2024 | theglobeandmail.com

NYC Arts Organization, Autumn Salon, Announces Next Concert 'Music Box'

February 20, 2024 | finance.yahoo.com

Sernova Corp (PSH.MU)

February 17, 2024 | morningstar.com

Sernova Corp SVA

April 16, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

January 9, 2024 | finance.yahoo.com

We Think Sernova (TSE:SVA) Can Afford To Drive Business Growth

November 27, 2023 | markets.businessinsider.com

Sernova Gets FDA Orphan Drug, Rare Pediatric Disease Designations For Hemophilia A Program

November 27, 2023 | finance.yahoo.com

Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA

October 11, 2023 | finance.yahoo.com

Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress

October 4, 2023 | markets.businessinsider.com

H.C. Wainwright Thinks Sernova’s Stock is Going to Recover

September 29, 2023 | markets.businessinsider.com

H.C. Wainwright Reaffirms Their Buy Rating on Sernova (SVA)

September 14, 2023 | markets.businessinsider.com

Sernova (SVA) Gets a Buy Rating from Echelon Wealth Partners

September 14, 2023 | finance.yahoo.com

Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22

September 13, 2023 | finance.yahoo.com

Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update

September 5, 2023 | markets.businessinsider.com

Echelon Wealth Partners Maintains Their Buy Rating on Sernova (SVA)

August 4, 2023 | theglobeandmail.com

Closing Bell: Sernova Corp flat on Wednesday (SVA)

August 2, 2023 | finance.yahoo.com

Is Sernova (TSE:SVA) In A Good Position To Invest In Growth?

July 26, 2023 | finance.yahoo.com

Sernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business Officer

May 3, 2023 | marketwatch.com

EQS-News: Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications

May 3, 2023 | finance.yahoo.com

Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications

April 29, 2023 | theglobeandmail.com

Closing Bell: Sernova Corp up on Friday (SVA)

April 21, 2023 | theglobeandmail.com

Closing Bell: Sernova Corp flat on Friday (SVA)

April 19, 2023 | theglobeandmail.com

Closing Bell: Sernova Corp down on Tuesday (SVA)

See More Headlines

Receive SVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/18/2024
Today: 4/16/2024
Next Earnings (Estimated): 6/11/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: TSE:SVA
CUSIP: N/A
CIK: N/A
Web: www.sinovacbio.com
Phone: 861082890088
Fax: N/A
Employees: 1,959
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: C$1.50
High Stock Price Target: C$1.50
Low Stock Price Target: C$1.50
Potential Upside/Downside: +219.1%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($0.13)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-40,730,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -183.58%
Return on Assets: -79.96%

Debt

Debt-to-Equity Ratio: 16.55
Current Ratio: 1.20
Quick Ratio: 18.11

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: C$0.08 per share
Price / Cash Flow: 6.15
Book Value: C$0.01 per share
Price / Book: 47.00

Miscellaneous

Outstanding Shares: 303,410,000
Free Float: N/A
Market Cap: C$142.60 million
Optionable: Not Optionable
Beta: 1.60

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Dr. Philip M. Toleikis B.A.
M.Sc., Ph.D., President, CTO, Director of Technology & Director
Mr. Christopher Barnes
Vice President of Investor Relations
Dr. Frank Shannon M.D.
Vice President of Clinical Development & Regulatory Affairs
Ms. Cynthia Pussinen
CEO & Director
Mr. Nicholas J. Rossettos CPA (Age 58)
M.B.A., Interim Chief Financial Officer
Mr. Douglas Maret
Chief Science Officer
Dr. Modestus Obochi M.B.A.
Ph.D., Chief Business Officer

Key Competitors

View All Competitors

SVA Stock Analysis - Frequently Asked Questions

Should I buy or sell Sernova stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sernova in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SVA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SVA, but not buy additional shares or sell existing shares.
View SVA analyst ratings or view top-rated stocks.
What is Sernova's stock price target for 2024?: 1 Wall Street analysts have issued 12-month price targets for Sernova's stock. Their SVA share price targets range from C$1.50 to C$1.50. On average, they anticipate the company's share price to reach C$1.50 in the next twelve months. This suggests a possible upside of 219.1% from the stock's current price.
View analysts price targets for SVA or view top-rated stocks among Wall Street analysts.
How have SVA shares performed in 2024?: Sernova's stock was trading at C$0.70 at the start of the year. Since then, SVA stock has decreased by 32.9% and is now trading at C$0.47.
View the best growth stocks for 2024 here.
When is Sernova's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024.
View our SVA earnings forecast.

How were Sernova's earnings last quarter?: Sernova Corp. (TSE:SVA) released its quarterly earnings results on Monday, March, 18th. The company reported ($0.03) earnings per share for the quarter, hitting the consensus estimate of ($0.03).
How do I buy shares of Sernova?: Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:SVA) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sernova (SVA) Stock Price, News & Analysis

Sernova MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Sernova Stock (TSE:SVA)

SVA Stock Price History

SVA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SVA Stock Analysis - Frequently Asked Questions

Overall MarketRank^™